HALOZYME THERAPEUTICS, INC. — Director's Dealing 2017

Sep 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HALOZYME THERAPEUTICS INC (HALO)
CIK: 0001159036
Period of Report: 2017-09-21

Reporting Person: MATSUI CONNIE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-21	Common Stock	G	15000	—	Disposed	232388	Direct

Footnotes

F1: Represents a bona fide gift to a charitable organization.